The data showed (Figure 5D,G) that in T2DM PRP, the level of angiogenin increased (p = 0.001) and the level of VEGF decreased (p = 0.002) relative to PRP from healthy donors. This evidence concerns the gene VEGFA and type 2 diabetes mellitus.